Recruiting Depression Studies in Santa Monica
Psilocybin for Major Depressive Disorder (MDD)
Approximately 240 eligible adult participants (≥18 years old) who meet Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) criteria for Major Depressive Disorder (MDD) will be enrolled. P...
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Major Depressive Disorder - Emerge...
About Depression Clinical Trials in Santa Monica
Depression (major depressive disorder) is a common and serious mood disorder that negatively affects how you feel, think, and handle daily activities. It affects over 280 million people globally. Treatment includes psychotherapy, antidepressant medications, and brain stimulation therapies.
There are currently 2 depression clinical trials recruiting participants in Santa Monica, CALIFORNIA. These studies are seeking a combined 380 participants. Research is being sponsored by Usona Institute, Mind Medicine, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Depression Clinical Trials in Santa Monica — FAQ
Are there depression clinical trials in Santa Monica?
Yes, there are 2 depression clinical trials currently recruiting in Santa Monica, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Santa Monica?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.
Are clinical trials in Santa Monica free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.
What depression treatments are being tested?
The 2 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for depression.
Data updated March 2, 2026 from ClinicalTrials.gov